Nantong JiangTian Chemical (300927)

Search documents
江天化学:2023年半年度募集资金存放与使用情况的专项报告
2023-08-17 11:08
证券代码:300927 证券简称:江天化学 公告编号:2023-029 南通江天化学股份有限公司董事会 2023 年半年度募集资金存放与使用情况的专项报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 根据《深圳证券交易所创业板股票上市规则》和《深圳证券交易所上市公司 自律监管指引第2号——创业板上市公司规范运作》等有关规定,南通江天化学 股份有限公司(以下简称"公司"或"本公司")董事会编制了2023年半年度募 集资金存放与使用情况专项报告,说明如下: 一、募集资金基本情况 (一)募集资金金额及到位时间 经中国证券监督管理委员会《关于同意南通江天化学股份有限公司首次公开 发行股票注册的批复》(证监许可[2020]3213 号)同意注册,公司首次公开发 行人民币普通股(A 股)2,005 万股,每股面值人民币 1.00 元,发行价格为 13.39 元,募集资金总额为 268,469,500.00 元,由保荐机构扣除保荐承销费用 28,500,000.00 元(不含增值税)后的余额 239,969,500.00 元,于 2020 年 12 月 31 日汇入本公 ...
江天化学:江天化学业绩说明会、路演活动等
2023-04-28 08:12
证券代码: 300927 证券简称:江天化学 南通江天化学股份有限公司投资者关系活动记录表 2023-001 感谢您的关注,公司暂无相关计划,后续若有相关事项,公 司将及时履行信息披露义务,谢谢! 感谢您的关注,截至 2022 年 12 月 31 日,公司股东人数为 8904 户,谢谢! 4、公司在手订单情况与去年同期相比,是否有所下降呢? 投资者您好,公司目前生产经营及订单情况正常,2023 年 一季度报告已披露,还请参阅,谢谢关注。 5、公司所处精细化工赛道发展情况如何? 感谢您的关注,精细化工产品具有应用领域相对较为集中、 产业链长而复杂的特点,是传统化工产业结构升级调整的重点发 展战略。公司专注于以甲醇下游深加工为产业链的高端专用精细 化学品的研发、生产和销售,高度重视安全生产和环境保护,不 断提升生产的绿色、智能及节能化水平,提升市场竞争力,谢谢! 6、公司今年是否会有并购计划? 感谢您的关注,公司暂无并购计划,若有相关计划,公司将 及时履行信息披露义务,谢谢! 7、公司有无股权激励、员工持股计划? | 投资者关系活动 | □ 特定对象调研 □ 分析师会议 □ | | | --- | --- | - ...
江天化学(300927) - 2023 Q1 - 季度财报
2023-04-17 16:00
Financial Performance - The company's operating revenue for Q1 2023 was ¥191,495,027.31, a decrease of 0.69% compared to ¥192,823,700.32 in the same period last year[4] - Net profit attributable to shareholders was ¥22,822,001.97, down 3.95% from ¥23,761,074.89 year-on-year[4] - In Q1 2023, the company's net profit was CNY 22,822,001.97, a decrease of 3.94% compared to CNY 23,761,074.89 in Q1 2022[21] - Operating profit for Q1 2023 was CNY 30,260,350.02, down from CNY 31,552,462.99 in the same period last year, reflecting a decline of 4.07%[21] - The total profit for Q1 2023 was CNY 30,246,512.45, a decrease of 3.92% from CNY 31,556,892.99 in Q1 2022[21] - The company reported a tax expense of CNY 7,424,510.48, down from CNY 7,795,818.10 in the same quarter last year[21] - Basic and diluted earnings per share for Q1 2023 were both CNY 0.1581, down from CNY 0.1646 in Q1 2022[22] Cash Flow and Liquidity - The net cash flow from operating activities surged by 1,655.33% to ¥19,212,911.99, compared to ¥1,094,546.39 in the previous year[4] - The company's cash and cash equivalents decreased to CNY 183,325,410.40 from CNY 304,825,221.45 at the beginning of the year, representing a decline of 39.8%[16] - The cash and cash equivalents at the end of Q1 2023 stood at CNY 183,325,410.40, compared to CNY 176,310,881.70 at the end of Q1 2022[25] - The company reported a net cash outflow from investing activities of CNY -140,620,266.01, a significant increase from CNY -9,775,138.07 in the previous year[25] Assets and Liabilities - Total assets increased by 3.17% to ¥819,418,145.97 from ¥794,275,427.11 at the end of the previous year[4] - The total assets as of March 31, 2023, amounted to CNY 819,418,145.97, compared to CNY 794,275,427.11 at the beginning of the year, marking a growth of 3.2%[18] - The total liabilities increased to CNY 159,452,026.12 from CNY 157,261,874.04, a rise of 1.4%[18] - The company's retained earnings increased to CNY 250,950,763.63 from CNY 228,128,761.66, reflecting a growth of 9.9%[18] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 7,935[9] - The largest shareholder, Nantong Industrial Holding Group Co., Ltd., holds 37.53% of the shares[10] Government Support and Projects - The company received government subsidies amounting to ¥85,221.92 during the reporting period[5] - The company has successfully obtained various approvals for the "South District Project," which is aimed at enhancing safety and environmental standards[13] - The company acquired land use rights for a new project in Nantong, furthering its expansion strategy[14] Operating Costs - Total operating costs for Q1 2023 were CNY 160,844,793.97, down from CNY 161,730,954.00 year-on-year[20] - Accounts receivable increased to CNY 71,672,589.98 from CNY 61,225,113.38, reflecting a growth of 17.9%[16] - Inventory rose to CNY 56,595,071.91 from CNY 52,582,270.86, indicating an increase of 7.6%[16] Return on Equity - The weighted average return on equity decreased to 3.52% from 3.91% year-on-year[4]
江天化学(300927) - 2022 Q4 - 年度财报
2023-04-17 16:00
Financial Performance - The company's operating revenue for 2022 was approximately ¥737.29 million, representing a 3.85% increase compared to ¥709.97 million in 2021[16]. - The net profit attributable to shareholders decreased by 15.87% to approximately ¥63.79 million from ¥75.83 million in the previous year[16]. - The net profit after deducting non-recurring gains and losses was approximately ¥61.33 million, down 16.63% from ¥73.56 million in 2021[16]. - Basic earnings per share decreased by 15.88% to ¥0.4419 from ¥0.5253 in the previous year[16]. - The total assets at the end of 2022 were approximately ¥794.28 million, a 2.25% increase from ¥776.79 million at the end of 2021[16]. - The net assets attributable to shareholders increased by 6.82% to approximately ¥637.01 million from ¥596.32 million in 2021[16]. - The total profit for 2022 was 82.57 million yuan, a decrease of 6.30% compared to the previous year[55]. - The earnings per share for 2022 was 0.4419 yuan, down 15.88% from the previous year[55]. - The company reported a total revenue for 2022 of 5,725 million, an increase from 3,432 million in 2021, representing a growth of approximately 66.9%[138]. - The company reported a net profit of 287.5 million for 2022, compared to 30 million in 2021, indicating a significant increase of 858.3%[138]. Cash Flow and Investments - The net cash flow from operating activities increased significantly by 105.36% to approximately ¥79.05 million, compared to ¥38.49 million in 2021[16]. - The company's cash flow from operating activities showed a strong upward trend, particularly in Q3 2022, where it reached CNY 33.04 million[18]. - Investment cash inflow surged to ¥114,848,859.04, a 104.96% increase, while cash outflow decreased by 81.25% to ¥24,701,804.07, leading to a net cash flow from investing activities of ¥90,147,054.97, a 219.12% increase[77]. - The company reported a total investment of ¥553,524,795.35 in 2022, marking a substantial increase of 308.79% compared to ¥135,406,794.07 in the previous year[86]. - The company reported a total of RMB 22.85 million in unused raised funds as of the end of the reporting period[98]. - The company is actively managing its cash reserves, with a portion of raised funds allocated to bank deposits[98]. Production and Operations - The company’s main products include granular polyformaldehyde and formaldehyde, with the latter capable of producing high concentrations of up to 55%[29]. - The production capacity utilization rate for formaldehyde (37% concentration) is 93.11%, while the utilization rate for polyoxymethylene (96% content) is 66.68%[45]. - The production of polyoxymethylene was 53,347.75 tons, with sales of 53,107.45 tons, generating revenue of ¥315.48 million[65]. - In 2022, the sales volume of formaldehyde (37% concentration) increased by 10.96% year-on-year, reaching 228,757.97 tons, while production volume rose by 2.95% to 372,427.64 tons[66]. - The company completed the construction and acceptance of a project with an annual production capacity of 1,000 tons of 1,3,5-trisacryloylhexahydro-s-triazine in November 2022[67]. Research and Development - The company is focused on technological innovation and has developed multiple patented technologies, including a catalyst filling machine and a high-efficiency mixed aldehyde concentration device[43][44]. - The company applied for 2 patents in 2022, including 1 invention patent and received 1 invention patent and 4 utility model patents[48]. - The company has set up a technology research and development center to encourage innovation and ensure the quality of research outcomes[177]. - The company is focusing on R&D innovation to enhance new processes and technologies, with an emphasis on increasing product models and improving production efficiency[110]. Market and Competitive Position - The company aims to enhance its market competitiveness by optimizing its product structure and expanding its industrial chain related to methanol-based materials[36]. - The company is actively expanding its customer base, with a focus on both domestic and international sales[35]. - The company is targeting the expansion of foreign trade markets, particularly in high-end regions of Europe, the United States, Japan, and South Korea[108]. - The company is focused on expanding its market presence and enhancing its product offerings through ongoing research and development initiatives[141]. Environmental and Safety Initiatives - The company emphasizes safety and environmental protection, continuously improving its production processes to meet stringent regulatory requirements[27]. - The company has signed an investment agreement to build an environmental protection enhancement project, aiming to optimize product structure and reduce carbon emissions[28]. - The company has established an environmental self-monitoring plan in accordance with regulations and monitoring frequency requirements[200]. - The company has implemented a safety and environmental management system to comply with national laws and industry standards[181]. Corporate Governance and Management - The company has established a robust corporate governance structure, complying with relevant laws and regulations to protect shareholder interests[119]. - The board of directors consists of 9 members, including 3 independent directors, ensuring compliance with governance standards[122]. - The company has a diverse management team with extensive experience in various roles within the chemical industry[147][148][149]. - The company is committed to maintaining compliance with regulatory requirements and ensuring effective oversight through its board and supervisory committee[146]. Employee and Community Engagement - The company has established a charity fund with a donation of 200,000 yuan to support internal employees in need, enhancing employee satisfaction and reducing turnover rates significantly in 2022[40]. - The total number of employees at the end of the reporting period was 214, with 129 in production, 15 in sales, 41 in technical roles, 6 in finance, and 23 in administration[164]. - The company conducted internal training programs to enhance employees' professional skills and overall capabilities[166]. - The company is committed to improving employee living conditions through renovations and relocations of dormitories, contributing to a positive corporate culture[40].
江天化学:关于举行2022年度业绩说明会的公告
2023-04-17 10:34
证券代码:300927 证券简称:江天化学 公告编号:2023-007 (问题征集专题页面二维码) 出席本次年度业绩说明会的人员有:公司董事长、总经理朱辉先生;副总经 理、财务负责人、董事会秘书史彬先生;独立董事郁东先生;保荐代表人赵宏女 士等。 为充分尊重投资者、提升交流的针对性,现就公司 2022 年度业绩说明会提 前向投资者公开征集问题,广泛听取投资者的意见和建议。投资者可于 2023 年 4 月 26 日(星期三)15:00 前访问全景网(http://ir.p5w.net/zj/),或扫描 下方二维码,进入问题征集专题页面。公司将在 2022 年度业绩说明会上,对投 资者普遍关注的问题进行交流。 欢迎广大投资者积极参与本次网上说明会。 南通江天化学股份有限公司 关于举行2022年度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整, 没有虚假记载、误导性陈述或重大遗漏。 南通江天化学股份有限公司(以下简称"公司")已于 2023 年 4 月 18 日披 露《2022 年年度报告》,为使投资者更全面了解公司的经营成果、财务状况及未 来发展规划,公司计划于 2023 年 4 月 ...
江天化学(300927) - 2022 Q3 - 季度财报
2022-10-24 16:00
Financial Performance - The company's revenue for Q3 2022 was CNY 174,176,482.54, representing a 2.90% increase year-over-year, while the year-to-date revenue reached CNY 551,349,266.65, up 6.48% compared to the same period last year[4] - Net profit attributable to shareholders for Q3 2022 was CNY 11,196,497.90, a decrease of 18.77% year-over-year, and the year-to-date net profit was CNY 50,806,666.27, down 7.03% compared to the previous year[4] - Basic and diluted earnings per share for Q3 2022 were both CNY 0.0776, reflecting an 18.74% decline year-over-year[4] - Total operating revenue for the period reached ¥551,349,266.65, an increase of 6.5% compared to ¥517,776,754.75 in the previous period[23] - Net profit for the period was ¥50,806,666.27, a decrease of 7.5% from ¥54,648,125.18 in the previous period[24] - Earnings per share (basic and diluted) decreased to ¥0.3519 from ¥0.3786, representing a decline of 7.1%[25] Cash Flow - The net cash flow from operating activities for the year-to-date period increased significantly by 318.18%, amounting to CNY 54,023,752.89[4] - The net cash flow from operating activities for Q3 2022 was ¥54,023,752.89, a significant improvement compared to a net outflow of ¥24,761,311.43 in Q3 2021[28] - Cash generated from operating activities was ¥571,768,499.48, significantly higher than ¥406,564,009.50 in the previous period, indicating a growth of 40.6%[27] - The net cash flow from investing activities for the year-to-date period was CNY 8,458.16 million, a 283.42% increase compared to the previous year[12] - Total cash inflow from investment activities reached ¥488,959,222.56, compared to ¥26,073,666.67 in the same period last year[28] - The net cash flow from investment activities was ¥84,581,616.52, recovering from a net outflow of ¥46,112,968.91 in Q3 2021[28] - Cash outflow from financing activities totaled ¥37,329,527.01, a decrease from ¥53,883,558.93 in Q3 2021[28] - The net increase in cash and cash equivalents was ¥101,941,793.29, contrasting with a decrease of ¥124,933,110.80 in the previous year[28] Assets and Liabilities - Total assets at the end of Q3 2022 were CNY 784,606,363.38, showing a 1.01% increase from the end of the previous year[4] - The total liabilities decreased to ¥160,580,644.94 from ¥180,469,639.11, a reduction of 11.0%[24] - The company’s equity attributable to shareholders increased by 4.65% year-over-year, reaching CNY 624,025,718.44[4] - The total equity attributable to shareholders increased to ¥624,025,718.44 from ¥596,316,652.17, reflecting a growth of 4.7%[24] - Cash and cash equivalents amount to 287,384,480.51 yuan, up from 185,442,687.22 yuan at the beginning of the year[21] Investments and Expenses - The company reported a significant increase in investment income, which rose to CNY 205.10 million, a year-over-year increase of 2,851.08% due to cash management strategies[10] - The company received government subsidies amounting to CNY 278,892.48 in Q3 2022, contributing to its other income[5] - The company’s financial expenses decreased by 82.93% year-over-year, amounting to CNY 57.76 million, due to reduced borrowing costs[10] - Research and development expenses were ¥4,902,280.91, slightly down from ¥5,086,972.67, indicating a decrease of 3.6%[24] - Long-term borrowings decreased to ¥8,500,000.00 from ¥21,500,000.00, a significant reduction of 60.5%[24] - The company reported a tax expense of ¥16,221,222.05, which is an increase from ¥9,691,391.66, reflecting a rise of 67.0%[24] Shareholder Information - Total number of common shareholders at the end of the reporting period is 8,770[14] - The largest shareholder, Nantong Industrial Holdings, holds 37.53% of shares, totaling 54,180,000 shares[14] - The number of restricted shares held by Chen Mei increased to 1,061,000 shares due to executive lock-up[17] - The company has not disclosed any other related party relationships among shareholders[14]
江天化学(300927) - 2022 Q2 - 季度财报
2022-08-22 16:00
Financial Performance - The company's operating revenue for the first half of 2022 was ¥377,172,784.11, representing an increase of 8.22% compared to ¥348,510,895.40 in the same period last year[21]. - The net profit attributable to shareholders of the listed company decreased by 3.07% to ¥39,610,168.37 from ¥40,864,166.08 in the previous year[21]. - The basic earnings per share decreased by 3.07% to ¥0.2744, down from ¥0.2831 in the previous year[21]. - The total profit reached 52.03 million yuan, reflecting an 8.20% year-on-year growth[34]. - The total comprehensive income for the first half of 2022 was CNY 39,610,168.37, compared to CNY 40,864,166.08 in the first half of 2021, showing a decrease of approximately 3.1%[152]. - The company reported a net cash flow from operating activities of CNY 20,988,100.35 for the first half of 2022, a significant improvement compared to a net outflow of CNY 31,991,955.48 in the same period of 2021[154]. Assets and Liabilities - The total assets at the end of the reporting period were ¥773,608,153.90, a slight decrease of 0.41% from ¥776,786,291.28 at the end of the previous year[21]. - The total liabilities decreased to CNY 160,674,459.30 from CNY 180,332,835.44, indicating a reduction of approximately 10.1%[149]. - The company's cash and cash equivalents increased to ¥280,328,828.87, representing 36.24% of total assets, up from 23.87% last year, a change of 12.37%[46]. - Accounts receivable decreased slightly to ¥58,594,779.60, accounting for 7.57% of total assets, down from 7.85%[46]. - The total current liabilities decreased slightly to CNY 49,721,659.53 from CNY 50,470,754.49, a reduction of approximately 1.5%[144]. Investment and Cash Flow - The net cash flow from investment activities surged by 2,184.23%, reaching 110.71 million yuan, attributed to increased structured deposits[41]. - The company reported a significant increase in investment, with a total of ¥304,029,627.47 during the reporting period, a 2,655.22% increase compared to ¥11,034,666.12 in the same period last year[51]. - The company’s cash flow from investment activities showed a net inflow of ¥97,492,267.66, compared to a net outflow of ¥5,264,884.09 in the first half of 2021[158]. Research and Development - Research and development investment amounted to 12.47 million yuan, a 7.52% increase from the previous year[41]. - Research and development expenses for the first half of 2022 were CNY 3,151,241.27, slightly down from CNY 3,168,891.95 in the first half of 2021, indicating a decrease of about 0.6%[151]. Corporate Governance and Compliance - The company is committed to enhancing compliance culture and risk prevention capabilities within its operations[34]. - The company has implemented ISO9001 and ISO14001 standards for quality and environmental management, ensuring compliance with safety and environmental regulations[33]. - The company has established a rigorous accounts receivable management system, ensuring stable customer credit quality, but remains cautious of potential risks due to economic changes[71]. Shareholder Information - The company plans not to distribute cash dividends or issue bonus shares[5]. - The company approved a profit distribution plan on May 13, 2022, distributing a cash dividend of 2.88 RMB per 10 shares, totaling 23,097,600 RMB (before tax) to shareholders[121]. - The total number of ordinary shareholders at the end of the reporting period was 10,210[129]. Environmental and Safety Practices - The company has implemented upgrades to pollution control facilities, ensuring stable compliance with emission standards[82]. - The company has established a long-term safety education and training plan to enhance safety and environmental governance levels[84]. - The company has taken measures to reduce carbon emissions, although specific details were not disclosed[83]. Market Position and Strategy - The company focuses on the research, production, and sales of high-end specialty fine chemicals derived from downstream processing of methanol, with a significant market position in the chemical raw materials and products manufacturing industry[29]. - The company has a significant market share and pricing power in the specialty chemicals sector, driven by its advanced technology and product quality[31]. - The company emphasizes sustainable development and aims to enhance market competitiveness through green, low-carbon, and low-energy consumption production practices[30].
江天化学(300927) - 2022 Q1 - 季度财报
2022-04-18 16:00
Financial Performance - The company's revenue for Q1 2022 was ¥192,823,700.32, representing a 12.06% increase compared to ¥172,072,613.51 in the same period last year[4] - Net profit attributable to shareholders was ¥23,761,074.89, up 10.06% from ¥21,589,671.96 year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥23,055,900.66, marking a 15.68% increase from ¥19,930,029.10 in the previous year[4] - Total operating revenue for Q1 2022 was CNY 192,823,700.32, an increase of 12.9% compared to CNY 172,072,613.51 in Q1 2021[23] - Net profit for Q1 2022 reached CNY 23,761,074.89, representing a 10.1% increase from CNY 21,589,671.96 in Q1 2021[24] - Earnings per share for Q1 2022 were CNY 0.2963, compared to CNY 0.2692 in Q1 2021, marking an increase of 10.5%[25] Cash Flow - The net cash flow from operating activities improved significantly to ¥1,094,546.39, a 106.40% increase from a negative cash flow of ¥17,092,173.12 in the previous year[4] - Cash flow from operating activities for Q1 2022 was CNY 178,927,228.14, significantly higher than CNY 119,612,477.01 in Q1 2021, indicating a growth of 49.5%[27] - Total cash inflow from operating activities amounted to 180,281,999.77, while cash outflow was 179,187,453.38, resulting in a net increase of 1,094,546.39[28] - The company reported a cash balance of 176,310,881.70 at the end of the period, down from 243,712,937.18 at the beginning of the period[29] - The company received a tax refund of 1,662,198.23 during the reporting period[28] Assets and Liabilities - Total assets at the end of the reporting period were ¥810,950,799.74, an increase of 4.40% from ¥776,786,291.28 at the end of the previous year[4] - Total current assets as of March 31, 2022, amounted to RMB 479,875,000.13, an increase from RMB 441,072,801.99 at the beginning of the year, reflecting a growth of approximately 8.5%[19] - Total liabilities for Q1 2022 were CNY 190,873,072.68, compared to CNY 180,469,639.11 in Q1 2021, reflecting a rise of 5.5%[21] - The company's non-current assets totaled CNY 331,075,799.61, slightly down from CNY 335,713,489.29 in the previous year[21] Inventory and Expenses - The company reported a 34.06% increase in inventory, reaching ¥5,442.49 million, primarily due to rising prices of upstream raw materials[7] - Total operating costs for Q1 2022 were CNY 161,730,954.00, up from CNY 148,119,067.44 in the same period last year, reflecting a rise of 9.5%[23] - Financial expenses decreased by 97.23% to ¥5.03 million, attributed to reduced interest expenses from debt repayment and improved returns on deposits[8] - The company reported a tax expense of CNY 7,795,818.10 for Q1 2022, compared to CNY 3,851,359.67 in Q1 2021, indicating a significant increase in tax obligations[24] Shareholder Information - The company had a total of 9,715 ordinary shareholders at the end of the reporting period[10] - The total number of shares held by the top 10 shareholders includes significant stakes from South Tong Industry Holding Group Co., Ltd. at 29.30%[12] - The company’s total restricted shares at the beginning of the period were 60,150,000, with 30,050,000 shares released during the period[14] Future Plans and Investments - The company plans to continue expanding its market presence and product development initiatives in the upcoming quarters[17] - The company has established a private equity fund, South Tong Changkong Investment Fund, in compliance with relevant regulations[16] Other Financial Activities - Cash inflow from investment activities was 129,830,894.48, while cash outflow totaled 139,606,032.55, leading to a net cash outflow of -9,775,138.07[29] - The company paid 10,000,000.00 in debt repayments during the financing activities[29] - The total cash outflow from financing activities was 457,187.51, compared to 20,135,336.11 in the previous year[29] - The company experienced a foreign exchange impact of 5,973.67 on cash and cash equivalents[29] Audit Status - The report for the first quarter was not audited[30]
江天化学(300927) - 2021 Q4 - 年度财报
2022-04-18 16:00
Financial Performance - The company's operating revenue for 2021 was CNY 709,974,754.86, representing a 62.20% increase compared to CNY 437,705,981.44 in 2020[19] - The net profit attributable to shareholders for 2021 was CNY 75,825,895.54, a 37.85% increase from CNY 55,005,268.81 in the previous year[19] - The net profit after deducting non-recurring gains and losses was CNY 73,563,224.75, up 40.23% from CNY 52,457,417.16 in 2020[19] - The basic earnings per share for 2021 was CNY 0.9455, reflecting a 3.39% increase from CNY 0.9145 in 2020[19] - The total assets at the end of 2021 amounted to CNY 776,786,291.28, a 2.06% increase from CNY 761,139,421.79 at the end of 2020[19] - The net assets attributable to shareholders increased by 10.98% to CNY 596,316,652.17 from CNY 537,332,756.63 in 2020[19] - The net cash flow from operating activities for 2021 was CNY 38,491,711.65, a decrease of 26.69% compared to CNY 52,504,544.53 in 2020[19] - The weighted average return on equity for 2021 was 13.41%, down from 19.25% in 2020, indicating a decline of 5.84%[19] Revenue and Sales - The company's total revenue for the four quarters of 2021 was approximately CNY 710 million, with the highest revenue in Q4 at CNY 192.2 million[21] - The net profit attributable to shareholders for the year was CNY 75.8 million, with Q1 showing the highest profit of CNY 21.6 million[21] - The net cash flow from operating activities turned positive in Q4, reaching CNY 63.3 million, after negative cash flows in the first three quarters[21] - The revenue from polyformaldehyde reached 347.54 million yuan, accounting for 48.95% of total revenue, with an impressive year-on-year growth of 85.44%[63] - Domestic sales contributed 88.68% of total revenue, amounting to 629.59 million yuan, while overseas sales accounted for 11.32%, totaling 80.39 million yuan, marking an 82.55% increase year-on-year[64] Production Capacity and Operations - The designed production capacity for formaldehyde is 400,000 tons/year with a utilization rate of 90.44%[51] - The production capacity for polyoxymethylene is 80,000 tons/year with a utilization rate of 73.35%[51] - The production capacity for ultra-pure chloromethane is 20,000 tons/year with a utilization rate of 50.83%[51] - The production capacity for 1,3,5-trisacryloylhexahydro-s-triazine is 1,000 tons/year for both slurry and powder, with a utilization rate of 99.90%[51] - The production capacity for polyformaldehyde increased from 45,000 tons to 80,000 tons, and formaldehyde capacity rose from 280,000 tons to 400,000 tons, contributing to significant performance improvement[60] Research and Development - In 2021, the company applied for 9 patents, including 1 invention patent and 8 utility model patents, and received authorization for 7 utility model patents[42] - The company has committed to ongoing technological research and development to enrich its product system and explore new markets[30] - The company has a dedicated R&D center to encourage innovation and ensure the quality of new product development[173] - The company is actively investing in research and development for new technologies, with a budget allocation of 595 million for innovation initiatives[131] Risk Management and Compliance - The company has outlined potential risks in its future development outlook, which investors should be aware of[6] - The company has established a comprehensive and effective internal control system to ensure compliance and asset security[169] - The company has implemented strict internal approval processes for financial reporting to ensure accuracy and reliability[174] - The company has established clear regulations for the management and use of raised funds to ensure transparency[175] Environmental and Safety Measures - The company aims to improve its safety and environmental protection capabilities in line with national policies, which may lead to accelerated industry consolidation[30] - The company has implemented upgrades to pollution control facilities, ensuring stable compliance with emission standards[187] - All construction projects have undergone environmental impact assessments and received necessary approvals, including pollution discharge permits[187] - The company has developed a scientific emergency response plan for environmental incidents, actively addressing potential environmental and safety risks[191] Governance and Management - The company has a clear organizational structure with defined roles and responsibilities, ensuring effective coordination among departments[126] - The company has a total of 3 independent directors who fulfill their duties independently and fairly, ensuring the protection of minority shareholders' rights[123] - The company held its first extraordinary general meeting of shareholders in 2021 with a participation rate of 71.86%[128] - The management team has undergone changes, with several key personnel resignations in April 2021, impacting strategic direction[132] Future Outlook - Future outlook indicates a projected revenue growth of 10% for the upcoming fiscal year, driven by new product launches and market expansion strategies[132] - The company plans to distribute a cash dividend of RMB 2.88 per 10 shares, totaling RMB 23,097,600 (including tax) based on a total share capital of 80,200,000 shares[166] - The company aims to enhance shareholder value through a proposed dividend increase of 10% in the next fiscal year[132] Employee Management and Development - The total number of employees at the end of the reporting period was 195, with 123 in production, 16 in sales, 25 in technical roles, 6 in finance, and 25 in administration[160] - Employee training programs focus on professional skills development, primarily through internal training supplemented by external training[163] - The company has established a dual promotion channel for technical and management positions to enhance employee motivation and organizational efficiency[114]
江天化学(300927) - 2021 Q3 - 季度财报
2021-10-25 16:00
Financial Performance - The company's operating revenue for Q3 2021 was ¥169,265,859.35, representing a 71.47% increase compared to the same period last year[3]. - The net profit attributable to shareholders for Q3 2021 was ¥13,783,959.10, an increase of 10.38% year-on-year[3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥13,848,533.13, up 12.66% from the previous year[3]. - Total operating revenue for the third quarter reached CNY 517,776,754.75, a significant increase of 67.2% compared to CNY 309,753,526.80 in the same period last year[19]. - Net profit for the period was CNY 54,648,125.18, representing a 28.7% increase from CNY 42,477,086.33 in the previous year[21]. Assets and Liabilities - The total assets at the end of Q3 2021 were ¥713,756,357.73, a decrease of 6.23% from the end of the previous year[3]. - The company's total assets decreased to CNY 713,756,357.73 from CNY 761,139,421.79, a decline of 6.2%[18]. - Total liabilities decreased to CNY 138,617,475.92 from CNY 223,806,665.16, a reduction of 38.1%[18]. - The company's equity attributable to shareholders increased to CNY 575,138,881.81 from CNY 537,332,756.63, an increase of 7.0%[18]. Cash Flow - The company reported a net cash flow from operating activities of -¥24,761,311.43, a decline of 176.32% compared to the same period last year[3]. - The cash flow from operating activities showed a significant increase, with cash received from sales reaching CNY 406,564,009.50, compared to CNY 283,691,797.98 in the previous year[23]. - Total cash inflow from operating activities was 412,274,534.56, while cash outflow was 437,035,845.99, resulting in a net cash flow deficit[25]. - Cash flow from investing activities showed a net outflow of -46,112,968.91, compared to -9,669,797.90 in the previous year[25]. - Cash flow from financing activities resulted in a net outflow of -53,883,558.93, compared to -44,118,671.92 in the same period last year[26]. Costs and Expenses - The company's gross profit margin was impacted by rising raw material prices, leading to an increase in operating costs by 78.45% year-on-year[9]. - Total operating costs amounted to CNY 455,963,771.34, up 73.6% from CNY 262,710,568.56 year-on-year[19]. - The company experienced a significant increase in sales expenses by 46.15% due to higher performance bonuses and storage costs[9]. - Research and development expenses for the quarter were CNY 5,086,972.67, compared to CNY 4,589,790.22 in the previous year, reflecting a growth of 10.9%[19]. - The company reported a total of 27,859,042.97 in cash paid to employees, an increase from 21,568,757.50 in the previous year[25]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 10,919[12]. - The largest shareholder, Nantong Industrial Holding Group Co., Ltd., holds 37.53% of shares, totaling 30,100,000 shares[12]. - The total number of restricted shares at the end of the period is 60,150,000, with 1,034,962 shares released from restriction during the period[15]. Future Plans and Developments - The company plans to expand its production capacity for formaldehyde and related products, which is expected to contribute to revenue growth[9]. - The company received a notification in July 2021 regarding relocation and upgrading, aimed at promoting ecological development and supporting the high-end specialty chemical industry[13]. - The company plans to gradually complete the relocation as new factories are built, impacting the implementation of fundraising projects[13]. - The company is assessing the impact of the relocation on its operational strategy and fundraising projects[13]. Inventory and Investments - As of September 30, 2021, total current assets amount to 366,320,170.32 RMB, while total non-current assets are 347,436,187.41 RMB[16]. - The company reported cash and cash equivalents of 159,964,060.82 RMB, a decrease from 284,897,171.62 RMB in the previous period[16]. - Inventory increased to 40,310,474.67 RMB from 31,558,981.69 RMB in the previous period, indicating a growth of approximately 27.5%[16]. - The company has a long-term equity investment of 13,000,000 RMB[16]. - The company reported an investment income of CNY 69,496.86, indicating positive returns from its investments[21]. Miscellaneous - The basic earnings per share for Q3 2021 was ¥0.1719, down 17.20% year-on-year[3]. - Basic and diluted earnings per share were both CNY 0.6814, slightly down from CNY 0.7062 in the same quarter last year[22]. - The ending balance of cash and cash equivalents was 159,964,060.82, down from 284,897,171.62 at the beginning of the period[26]. - The company did not adjust the beginning balance sheet items due to the new leasing standards as the leases involved were short-term[27]. - The third-quarter report was not audited[28].